Catalyst Pharmaceutical Partners Inc buy StockNews.com
Start price
11.01.25
/
50%
€21.73
Target price
11.01.26
-
Performance (%)
-17.95%
Price
03.10.25
€17.83
Summary
This prediction is currently active. The prediction for Catalyst Pharmaceutical Partners Inc disappoints with a performance of -17.95%. This prediction currently runs until 11.01.26. The prediction end date can be changed by StockNews_com at any time. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Catalyst Pharmaceutical Partners Inc | 6.894% | 6.894% |
| iShares Core DAX® | 2.709% | 3.467% |
| iShares Nasdaq 100 | 0.867% | 5.198% |
| iShares Nikkei 225® | 3.135% | 9.423% |
| iShares S&P 500 | 0.886% | 3.586% |
Comments by StockNews_com for this prediction
In the thread Catalyst Pharmaceutical Partners Inc diskutieren
Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Ratings data for CPRX provided by MarketBeat
Stopped prediction by StockNews_com for Catalyst Pharmaceutical Partners Inc
Catalyst Pharmaceutical Partners Inc
Start price
Target price
Perf. (%)
€16.81
21.09.25
21.09.25
-
21.09.26
21.09.26
6.10%
03.10.25
03.10.25
Catalyst Pharmaceutical Partners Inc
Start price
Target price
Perf. (%)
€20.62
04.01.25
04.01.25
-
04.01.26
04.01.26
-13.53%
03.10.25
03.10.25
Catalyst Pharmaceutical Partners Inc
Start price
Target price
Perf. (%)
€20.76
25.12.24
25.12.24
-
25.12.25
25.12.25
-14.11%
03.10.25
03.10.25
Catalyst Pharmaceutical Partners Inc
Start price
Target price
Perf. (%)
€14.43
08.06.24
08.06.24
-
08.06.25
08.06.25
59.39%
09.06.25
09.06.25